Key Financial Data Of Group

Kringle Pharma,Inc. - Filing #7357145

Concept As at
2023-12-31
2023-10-01 to
2023-12-31
2022-10-01 to
2023-09-30
As at
2023-09-30
As at
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of group
Business results of group
Net sales
18,690,000 JPY
69,250,000 JPY
17,365,000 JPY
Ordinary profit (loss)
-169,113,000 JPY
-852,660,000 JPY
-157,476,000 JPY
Net assets
2,361,483,000 JPY
2,021,702,000 JPY
2,632,614,000 JPY
Total assets
2,844,699,000 JPY
2,618,657,000 JPY
3,048,096,000 JPY
Basic earnings (loss) per share
-29.53
-158.46
-29.34
Diluted earnings per share
Equity-to-asset ratio
0.827 xbrli:pure
0.766 xbrli:pure
0.862 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.